awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38301000-2A98BB96-6857-490F-A969-81C6C60CD3B0
Q38301000-2A98BB96-6857-490F-A969-81C6C60CD3B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38301000-2A98BB96-6857-490F-A969-81C6C60CD3B0
Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.
P2860
Q38301000-2A98BB96-6857-490F-A969-81C6C60CD3B0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38301000-2A98BB96-6857-490F-A969-81C6C60CD3B0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
875481b53d7378b8884e08ef6b599a6faa78b94f
P2860
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.